Pilot Trial
In the pilot, 90% of intervention participants reduced their opioid dose by at least 50% before surgery compared with 17% in standard care. A pilot RCT with 77 participants tested feasibility and acceptability of the pharmacist-partnered o…
1 sources - 4 claims
In the pilot, 90% of intervention participants reduced their opioid dose by at least 50% before surgery compared with 17% in standard care. A pilot RCT with 77 participants tested feasibility and acceptability of the pharmacist-partnered opioid tapering intervention before THA or TKA. The pilot showed favourable signals for postoperative physical function and persistent opioid use but was not powered for those secondary outcomes. The intervention was acceptable to both participants and clinicians in the pilot.